Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

NCT00096525 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: lenalidomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]